Diseases, Conditions, Syndromes

Pfizer/BioNTech first dose 85% effective after 2-4 weeks: study

The first dose of the Pfizer/BioNTech vaccination is 85 percent effective against coronavirus infection between two and four weeks after inoculation, according to a study published in the Lancet medical journal.

Diseases, Conditions, Syndromes

Masks, gloves don't stop coronavirus spread: experts

Wearing masks and gloves as a precaution against coronavirus is ineffective, unnecessary for the vast majority of people, and may even spread infections faster, experts said Tuesday.

Diseases, Conditions, Syndromes

Most coronavirus infections are mild, says Chinese study

Most people infected by the new coronavirus in China have mild symptoms, with older patients and those with underlying conditions most at risk from the disease, according to a study by Chinese researchers.

Diseases, Conditions, Syndromes

Genome mapping may stop superbug deaths

Genome mapping could prove key in preventing superbugs in hospitals, an Australian researcher said Friday, urging its use to prevent countless deaths from antibiotic-resistant infections.

page 1 from 25